JSKN033 + BEVACIZUMAB + PLATINUM for uterine cervical neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Mar 2026: Trial registered, NCT07497074

The trials

NCT07497074: JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

State
Not started
Phase
Phase 2
People
78 planned
Started
Apr 2026
Primary completion
Oct 2027
Arms
Safety run-in dose cohort 1, Safety run-in dose cohort 2, Dose expansion cohort
Results
None posted
  1. 27 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.